The chief scientific officer for GlassesOff Inc. reported at the 2013 Annual Meeting of American Academy of Ophthalmology that the benefits of its technology “are persistent over time and have a long-term effect despite the expected age-related decline of near vision.” The presentation included results from 59 subjects who completed the basic two to four month program and who maintained the protocol of a few sessions per month. They were retested after a period of 2.5 years on average. Read more.
No comments:
Post a Comment